Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis

Indian Journal of Dermatology

Volumn 58, Issue 3, 2013, Pages 239-

  Sadeghian, Giti ^a   Ziaei, Hengameh ^b   Shirani Bidabadi, Leila ^a   Nilforoushzadeh, Mohammad Ali ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; Lupoid; Skin test; Sporotrichoid

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; SKIN INDURATION; SKIN LEISHMANIASIS; SKIN ULCER; SPOROTRICHOSIS;

EID: 84877137605     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.110838     Document Type: Article

References (14)

1. Ayatollahi J. Sporotrichoid cutaneous leishmaniasis in central Iran. Iran J Med Sci 2006;31:173-5.
2. Calvopina M, Gomez EA, Uezato H, Kato H, Nonaka S, Hashiguchi Y. Atypical clinical variants in New World cutaneous leishmaniasis: Disseminated, erysipeloid, and recidiva cutis due to Leishmania (V.) panamensis. Am J Trop Med Hyg 2005;73:281-4.
3. Manzur A, Bari A. Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis. Dermatol Online J 2006;12:2.
4. Bryceson AD. Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg 1969;63:708-37.
5. Salman SM, Rubeiz NG, Kibbi AG. Cutaneous leishmaniasis: Clinical features and diagnosis. Clin Dermatol 1999;17:291-6.
6. Sokal JE. Editorial: Measurement of delayed skin-test responses. N Engl J Med 1975;293:501-2.
7. Wong HT, Shahrizal TA, Prepageran N, Lim WK, Raman R. Cell-mediated immunity in nasopharyngeal carcinoma and allergic rhinitis: A controlled study. Ear Nose Throat J 2007;86:292-4.
8. Faber WR, Oskam L, van GT, Kroon NC, Knegt-Junk KJ, Hofwegen H, et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol 2003;49:70-4.
9. da Costa CA, de Toledo VP, enaro O, Williams P, Mayrink W. Montenegro skin test-evaluation of the composition and stability of the antigen preparation. Mem Inst Oswaldo Cruz 1996;91:193-4.
10. Mayrink W, Coelho GL, Guimarães TM, de Andrade HM, de Castro PE, da Costa CA, et al. Immuno-biochemical evaluations of phenol and thimerosal as antigen preservatives in Montenegro skin test. Acta Trop 2006;98:87-93.
11. Alexander J, Russell DG. The interaction of Leishmania species with macrophages. Adv Parasitol 1992;31:175-254.
12. Alimohammadian MH, Kivanjah M, Pak F, Gaznavia A, Kharazmi A. Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients. Trans R Soc Trop Med Hyg 1993;87:550-1.
13. Kubba R, al-Gindan Y, el-Hassan AM, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. II. Satellite papules and subcutaneous induration. Int J Dermatol 1988;27:702-6.
14. Masmoudi A, Ayadi N, Khabir A, Bouzid L, Bouassida S, Meziou TJ, et al. Sporotrichoid cutaneous leishmaniasis in Tunisia: A clinical and histological study. Ann Dermatol Venereol 2008;135:63-7.